Vitamin B3 (Niacinamide) — The NAD+ Precursor
Niacinamide, a form of Vitamin B3, is a water-soluble vitamin and a direct precursor to NAD+ (nicotinamide adenine dinucleotide). It plays a crucial role in cellular energy metabolism, DNA repair, and maintaining skin barrier function, making it relevant for both systemic longevity and dermatological aging.
Mechanism of Action
Niacinamide is a primary precursor in the NAD+ salvage pathway. It is converted to nicotinamide mononucleotide (NMN) by the enzyme NAMPT, and subsequently to NAD+. Elevated NAD+ levels are essential for the function of sirtuins (SIRT1-7) and PARPs, which regulate mitochondrial biogenesis, metabolic homeostasis, and DNA repair. Unlike niacin (nicotinic acid), niacinamide does not activate the GPR109A receptor, thus avoiding the characteristic 'niacin flush'.
Human Trial Evidence
Numerous human trials have demonstrated the efficacy of oral niacinamide in lowering the risk of non-melanoma skin cancers in high-risk populations (e.g., the ONTRAC trial, NEJM 2015). However, its systemic longevity benefits via NAD+ elevation in humans are less clearly established compared to other precursors like NR and NMN, partly due to potential feedback inhibition of sirtuins at high doses.
Dosing Protocol
For general health and skin cancer chemoprevention, oral doses of 500 mg twice daily are commonly used in clinical settings. For topical application, formulations containing 2% to 5% niacinamide are standard. High oral doses (above 1-2 g/day) are sometimes used but may require medical supervision.
Safety & Contraindications
Niacinamide is generally well-tolerated and does not cause the flushing associated with nicotinic acid. High doses (>3 g/day) can cause gastrointestinal upset, nausea, and potentially hepatotoxicity. It may also increase insulin resistance at very high doses, so caution is advised for individuals with metabolic syndrome or diabetes.